MOSCOW (MRC) -- Clariant, a world leader in specialty chemicals, has recently completed a significant expansion at its plant in Lewiston, ME, adding equipment that increases its capacity to compound high-temperature fluoropolymers, which include FEP, ETFE, and PVDF, as per the company's press release.
These materials are important for the production of medical catheters because of their flexibility, lubricity and chemical resistance. Demand for these polymers and for specialized masterbatches, which Clariant markets for medical applications under its MEVOPUR brand, continue to grow worldwide.
Another expansion at the Lewiston plant, planned for completion in 4Q 2017, will add another compounding line featuring a 70-mm extruder. This line will enable the plant to more rapidly produce larger batch sizes of MEVOPUR pre-colored medical plastic compounds.
Clariant already operates several smaller lines - in Lewiston and Clariant’s other MEVOPUR facilities - which produce masterbatches and pre-colored compounds in lot sizes ranging from 25 to 2500kg/50 to 5000 lbs. In addition, production capacity for compounds is also being added during the first half of 2017 in Singapore, to handle increasing demand of color compounds for local and international customers. These small- and medium-sized lots are in high demand, especially in the medical market, since many resin producers have discontinued or severely curtailed their custom-color offerings in anything smaller than full-truck or railcar quantities.
Clariant’s MEVOPUR materials are offered for applications in medical devices and pharmaceutical packaging, where strict regulations on materials and change control apply. The Lewiston plant is one of three global sites designed and operated to produce materials used in medical devices and pharmaceutical packaging. The other two facilities are located in Malmo, Sweden, and Singapore. All are certified to EN:ISO13485 (2012) and can use the same validated raw-material ingredients and processes so that the same products can be produced at any of the sites.
As MRC informed before, in March 2017, Clariant announced that it had been awarded a contract by Dongguan Grand Resource Science & Technology Co. Ltd. to develop a new propane dehydrogenation unit in cooperation with CB&I. The project includes the license and engineering design of the unit, which is to be built in Dongguan City, Guangdong Province, China. The Dongguan plant will be one of the largest single-train dehydrogenation units in the world. Clariant's technology partner CB&I will base the plant's design on its Catofin® catalytic dehydrogenation technology, which uses Clariant's tailor-made Catofin catalyst and Heat Generating Material (HGM).
Clariant AG is a Swiss chemical company and a world leader in the production of specialty chemicals for the textile, printing, mining and metallurgical industries. It is engaged in processing crude oil products in pigments, plastics and paints. Clariant India has local masterbatch production activities at Rania, Kalol and Nandesari (Gujarat) and Vashere (Maharashtra) sites in India.
MRC